This non-invasive procedure allows the doctor to see a much broader and more detailed view of the retina than is possible with conventional methods. When reviewed, the scan becomes a permanent part of your medical file, enabling your doctor to make important comparisons should potential vision-threatening conditions show themselves at a future examination. This instrument will enhance our ability to detect and monitor retinal defects associated with common systemic diseases such as hypertension, diabetes, high cholesterol, cancer, and thyroid problems. Through digital imaging of the retina, we can also observe early changes in the eye relating to glaucoma, cataracts, and macular degeneration. This technology is now our new standard of care. With this knowledge, we are aware that a condition with the potential for partial or total vision loss may exist, and without optomap retinal imaging, may go undetected and untreated.